ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009

MicroRNA Assay Detects Cancer Two Years Before LDCT in Study

January 31, 2014

Two Drugs Combined Better Than One Alone, Study Finds

February 27, 2009

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

NCI Programs: Study Finds Bomb Tests Raised I-131 Exposure in 1950’s, 1960’s

August 22, 1997